Morgans cuts Clinuvel Pharmaceuticals target price by 23% to A$10.00
Morgans cut its target price for Clinuvel Pharmaceuticals by 23% to A$10.00 per share.
Story updates
11:43:15 PM UTC
SquawkNews
Clinuvel Pharmaceuticals Target Price Cut 23% to A$10.00/Share by Morgans>CUV.AU
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.